Inflation, rising interest rates and uncertainty about changes to government heath programs could drag healthcare dealmaking in 2023, despite renewed interest in hospital and physician groups, according to an analysis the consulting firm PwC published Tuesday.
From May 2022 to May 2023, buyers invested $85.2 billion in 1,661 transactions for hospitals, health insurers, home health providers and other healthcare companies, PwC…